Dr. Sarah Whittle
6701 Fannin Street, Suite 1510
Houston, TX 77030
Dr. Whittle completed additional training to specialize in the care of patients with solid tumors, including neuroblastoma and bone tumors. She sees patients in the outpatient clinic and attends on the inpatient service at Texas Children’s Hospital. Dr. Whittle is board certified by the American Academy of Pediatrics in Pediatrics and Pediatric Hematology/Oncology. She is a member of the Solid Tumor Programs, where she is involved with the Bone Tumor Program, the Ewing Sarcoma Center and the Neuroblastoma Program.
Dr. Sarah Whittle’s research focuses on improving outcomes for children with neuroblastoma. Her primary efforts are focused on clinical trials for children with neuroblastoma, particularly related to the use of myeloid growth factors during induction chemotherapy. Dr. Whittle also researches healthcare costs associated with childhood cancer, with the goal of providing effective, high-value care for our patients.
MD, Warren Alpert Medical School at Brown University
MS, Clinical Investigation, Baylor College of Medicine
Fellowship, pediatric hematology/oncology, Baylor College of Medicine
Residency, Hasbro Children’s Hospital, Brown University
Internship, Hasbro Children’s Hospital, Brown University
Member, American Society of Pediatric Hematology and Oncology (ASPHO)
Member, Children’s Oncology Group (COG)